rubidium has been researched along with 7-chloro-3-isopropylamino-4h-1,2,4-benzothiadiazine 1,1-dioxide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antoine, MH; Arkhammar, P; Hansen, JB; Lebrun, P; Nguyen, QA; Pirotte, B | 1 |
1 other study(ies) available for rubidium and 7-chloro-3-isopropylamino-4h-1,2,4-benzothiadiazine 1,1-dioxide
Article | Year |
---|---|
A potent diazoxide analogue activating ATP-sensitive K+ channels and inhibiting insulin release.
Topics: Adenosine Triphosphate; Animals; Aorta; Benzothiadiazines; Blood Glucose; Cell Line; Diazoxide; Dose-Response Relationship, Drug; Fluorescent Dyes; Glyburide; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Isometric Contraction; Kinetics; Muscle, Smooth, Vascular; Potassium Channel Blockers; Potassium Channels; Rats; Rubidium | 2000 |